Skip to content

Protected: Studies

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability and Efficacy of GS-9674 in Subjects with Nonalcoholic Steatohepatitis (NASH)

Calendar Name GS-US-402-1852
Description The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in subjects with NASH as assessed by MRI-PDFF and MRE.
PI Mary Rinella
People -
Business Administrator -
Resources 1.5T Aera (CV)
IRB STU00204121
Start Date 2016-12-01
End Date 2018-12-31
Chart String 640-5316000-xxxxxxxx
Affiliates No